Dallas, Texas, United States The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Dallas.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the HM Capital, startups are often financed by NeSBIC CTe Fund, JP Morgan Chase & Co., Hudson River Capital Partners. The meaningful sponsors for the fund in investment in the same round are Flatiron Partners, Chase Capital Partners, ModusLink Global Solutions. In the next rounds fund is usually obtained by Tiger Global Management, Sequoia Capital, SSM Partners.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Despegar.com, Handango, The Realm. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Business Development, Software. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The current fund was established by Dan Blanks, Tom Hicks. The overall number of key employees were 2.
The higher amount of exits for fund were in 2010. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 28 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2000. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this HM Capital performs on 19 percentage points more the average number of lead investments.
Funds with similar focus
| Fund Name | Location |
| Andgo Partners | Budapest, Hungary |
| Capital Union Investments | China, Hong Kong, Hong Kong Island |
| Haofeng Group | - |
| IRDI-ICSO | France, Midi-Pyrenees, Toulouse |
| Itnig | Barcelona, Catalonia, Spain |
| Pay It Forward VC | - |
| Saidler & Co. | - |
| TA Capital | Houston, Texas, United States |
| Vnet Capital | Bangkok, Krung Thep, Thailand |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Osteal Therapeutics | $23M | 21 Sep 2023 | San Clemente, California, United States | ||
Porton Advanced Solutions | $80M | 21 Aug 2022 | Suzhou, Jiangsu, China | ||
Porton Biologics | $61M | 16 Apr 2021 | Suzhou, Jiangsu, China | ||
OncoImmune | $56M | 09 Sep 2020 | Maryland, United States | ||
| 02 Sep 2019 | China, Dongcheng District | ||||
Despegar | $10M | 25 May 2000 | Buenos Aires, Distrito Federal, Argentina | ||
Altitude Software | $27M | 12 May 2000 | Community of Madrid | ||
MercadoLibre | $46M | 11 May 2000 | Mendoza, Argentina | ||
The Realm | $140M | 04 May 2000 | New York, New York, United States |
– Sagimet Biosciences, a San Mateo, Calif.-based clinical-stage biotechnology company, raised $80m in crossover financing.
– The round was led by an undisclosed public equity healthcare investment fund with participation from existing investors (including Ascletis, Kleiner Perkins, New Enterprise Associates (NEA) and Rock Springs Capital) along with new investors (Altium Capital, HM Capital, Invus and PFM Health Sciences).
– The company intends to use the funds to advance its lead program, TVB-2640 for NASH, to explore additional indications, to file an IND on a second FASN inhibitor, TVB-3567, by the end of 2021.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Osteal Therapeutics | $23M | 21 Sep 2023 | San Clemente, California, United States | ||
Porton Advanced Solutions | $80M | 21 Aug 2022 | Suzhou, Jiangsu, China | ||
Porton Biologics | $61M | 16 Apr 2021 | Suzhou, Jiangsu, China | ||
OncoImmune | $56M | 09 Sep 2020 | Maryland, United States | ||
| 02 Sep 2019 | China, Dongcheng District | ||||
Despegar | $10M | 25 May 2000 | Buenos Aires, Distrito Federal, Argentina | ||
Altitude Software | $27M | 12 May 2000 | Community of Madrid | ||
MercadoLibre | $46M | 11 May 2000 | Mendoza, Argentina | ||
The Realm | $140M | 04 May 2000 | New York, New York, United States |
